US Patent Issued to The Board of Regents of The University of Texas System on Feb. 10 for "Pharmaceutical compositions targeting immune-mediated processes in neurodegenerative disease" (Texas Inventor)

ALEXANDRIA, Va., Feb. 11 -- United States Patent no. 12,545,722, issued on Feb. 10, was assigned to The Board of Regents of The University of Texas System (Austin, Texas).

"Pharmaceutical compositions targeting immune-mediated processes in neurodegenerative disease" was invented by Nancy Monson (Ovilla, Texas).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure in various aspects provides methods for making pharmaceutical compositions for treating neurodegenerative diseases (e.g., demyelinating diseases), such as but not limited to multiple sclerosis, neuromyelitis optica, and transverse myelitis. The pharmaceutical compositions impact specific antibody-mediated processes involved in the bio...